Â鶹´«Ã½

    Advertisement
    Hindustan Times01:52China South Africa Crime in India
    Genetic Engineering and Biotechnology News19:51China South Africa Crime in India
    Nature.com06:25Nature
    ecancer11:52Nature
    Genetic Engineering and Biotechnology News07:22Nobel Prizes Biology
    Drug Target Review04:05DNA Biology Genetics
    ScienceDaily12:44DNA Biology Genetics
    Longevity Technology12:07Biotechnology Biology
    Zacks09:36
    Nigerian Guardian02:01AI Nobel Prizes Biology
    Addgene09:19Genetics Biology
    Nature.com12:31Nature Biology
    In the last hour
    Graduate School of Arts and Sciences at Harvard University13:17
    In the last 6 hours
    The Motley Fool09:38
    FoodManufacture.co.uk08:59
    Earlier today
    Drugs Discovery Online02:33
    Yesterday
    Newswise (Press Release)00:19 2-Apr-25
    In the last 7 days
    Nasdaq16:59 1-Apr-25
    Longevity Technology12:07 1-Apr-25
    Addgene09:24 1-Apr-25
    Business Wire (Press Release)07:01 1-Apr-25
    Drug Target Review04:05 1-Apr-25
    The Scientist00:11 1-Apr-25
    The Motley Fool15:29 31-Mar-25
    Zacks09:36 31-Mar-25
    PR Newswire (Press Release)06:59 31-Mar-25
    Mother Jones06:03 31-Mar-25
    Eurasia Review19:17 29-Mar-25
    Zacks10:03 28-Mar-25
    Business Wire (Press Release)09:14 28-Mar-25
    Genetic Engineering and Biotechnology News07:22 28-Mar-25
    ENDPOINTS07:08 28-Mar-25
    University of Plymouth06:12 28-Mar-25
    Nature.com20:17 27-Mar-25
    Genetic Engineering and Biotechnology News19:51 27-Mar-25
    Simply Wall St15:07 27-Mar-25
    PR Newswire (Press Release)11:51 27-Mar-25
    Newswise (Press Release)10:10 27-Mar-25
    News-Medical.Net09:43 27-Mar-25
    Nature.com06:25 27-Mar-25
    Industry Today05:17 27-Mar-25
    Nigerian Guardian02:01 27-Mar-25
    Hindustan Times01:52 27-Mar-25
    The Scientist00:05 27-Mar-25
    In the last month
    Nature.com21:52 26-Mar-25
    TipRanks16:31 26-Mar-25
    GlobeNewswire (Press Release)16:01 26-Mar-25
    Nature.com12:31 26-Mar-25
    Nature.com12:31 26-Mar-25
    Nature.com12:05 26-Mar-25
    PR Newswire (Press Release)10:12 26-Mar-25
    BioPharma Dive09:00 26-Mar-25
    Business Wire (Press Release)07:09 26-Mar-25
    Seeking Alpha21:15 25-Mar-25
    Nature.com12:26 25-Mar-25
    ecancer11:52 25-Mar-25
    Addgene09:19 25-Mar-25
    PR Newswire (Press Release)07:03 25-Mar-25
    News-Medical.Net12:20 24-Mar-25
    Newswise (Press Release)11:58 24-Mar-25
    GlobeNewswire (Press Release)05:11 24-Mar-25
    BBC Science Focus04:02 24-Mar-25
    ScienceDaily08:04 23-Mar-25
    The Niche (Weblog)04:52 23-Mar-25
    ISRAEL21c04:02 23-Mar-25
    News-Medical.Net22:44 22-Mar-25
    The Motley Fool16:06 22-Mar-25
    Newswise (Press Release)12:12 21-Mar-25
    University of Westminster07:02 21-Mar-25
    Newswise (Press Release)01:31 21-Mar-25
    TipRanks00:15 21-Mar-25
    Nature.com20:09 20-Mar-25
    Genetic Engineering and Biotechnology News16:39 20-Mar-25
    Seeking Alpha16:24 20-Mar-25
    GlobeNewswire (Press Release)16:05 20-Mar-25
    News-Medical.Net15:29 20-Mar-25
    YaleNews06:05 20-Mar-25
    Drugs Discovery Online03:02 20-Mar-25
    The Motley Fool18:17 19-Mar-25
    The Motley Fool15:04 19-Mar-25
    Nature.com12:39 19-Mar-25
    Big Think11:11 19-Mar-25
    PR Newswire (Press Release)10:34 19-Mar-25
    Zacks10:31 19-Mar-25
    King's College London07:39 19-Mar-25
    Pharmaceutical Technology06:55 19-Mar-25
    The Financial Express21:52 18-Mar-25
    GlobeNewswire (Press Release)10:53 18-Mar-25
    Investing.com UK09:55 18-Mar-25
    Addgene09:23 18-Mar-25
    ecancer07:30 18-Mar-25
    FierceBiotech06:43 18-Mar-25
    GlobeNewswire (Press Release)06:39 18-Mar-25
    ENDPOINTS06:30 18-Mar-25
    American Journal of Managed Care14:09 17-Mar-25
    News-Medical.Net14:03 17-Mar-25
    Newswise (Press Release)10:06 17-Mar-25
    RTT News09:35 17-Mar-25
    The Times of Israel05:04 17-Mar-25
    AgriMarketing03:12 17-Mar-25
    ScienceDaily12:44 16-Mar-25
    Nature.com03:27 16-Mar-25
    News-Medical.Net19:17 14-Mar-25
    Newswise (Press Release)15:01 14-Mar-25
    Vice (US)11:50 14-Mar-25
    Seeking Alpha11:38 14-Mar-25
    EurActiv.com06:58 14-Mar-25
    Nature.com01:34 14-Mar-25
    PR Newswire (Press Release)16:48 13-Mar-25
    GlobeNewswire (Press Release)11:09 13-Mar-25
    News-Medical.Net10:34 13-Mar-25
    GlobeNewswire (Press Release)06:20 13-Mar-25
    Discover Magazine18:10 12-Mar-25
    The Economic Times13:35 12-Mar-25
    Nature.com13:23 12-Mar-25
    Nature.com13:23 12-Mar-25
    Nature.com12:34 12-Mar-25
    Broad Institute of MIT and Harvard11:06 12-Mar-25
    Business Wire (Press Release)08:01 12-Mar-25
    TipRanks00:11 12-Mar-25
    Jerusalem Post19:52 11-Mar-25
    Business Wire (Press Release)11:33 11-Mar-25
    Boston Globe11:28 11-Mar-25
    Tel Aviv University09:07 11-Mar-25
    Pharmaceutical Technology07:57 11-Mar-25
    GlobeNewswire (Press Release)07:50 11-Mar-25
    Newswise (Press Release)07:47 11-Mar-25
    view more headlines
    3 Apr 13:17

    About our CRISPR/Gene Editing news

    Latest news on CRISPR/Gene Editing, covering breakthroughs, applications, ethics, regulations, and implications for health, agriculture, and biotechnology. Stay informed on this revolutionary technology.

    CRISPR/Cas9, the groundbreaking gene-editing tool, has revolutionised the field of genetics and biotechnology since its discovery in 2012. Developed by scientists Jennifer Doudna and Emmanuelle Charpentier, who were awarded the Nobel Prize in Chemistry in 2020, CRISPR allows for precise, efficient, and cost-effective editing of DNA sequences in living organisms.

    The potential applications of CRISPR are vast, spanning healthcare, agriculture, and beyond. In medicine, CRISPR holds promise for treating genetic disorders, developing novel therapies for diseases like cancer and HIV, and even potentially enhancing human traits. Recent breakthroughs include the first clinical trials of CRISPR-based treatments for sickle cell anemia and beta-thalassemia, as well as advancements in using CRISPR to target antibiotic-resistant bacteria.

    In agriculture, CRISPR is being explored to develop more resilient, nutritious, and sustainable crops, as well as to create disease-resistant livestock. Companies like Corteva Agriscience and Calyxt are at the forefront of these efforts. However, the use of CRISPR in agriculture has also sparked debates about GMO regulations, labelling, and public acceptance.

    Despite its immense potential, CRISPR also raises significant ethical and societal concerns. The prospect of human germline editing, which could alter the genetic makeup of future generations, has been particularly controversial. In 2018, Chinese scientist He Jiankui claimed to have created the world's first gene-edited babies, sparking global outcry and calls for stricter oversight. Organizations like the World Health Organization and the National Academies of Sciences have issued guidelines and recommendations for the responsible development and governance of gene editing.

    Stay up-to-date on the latest CRISPR/Gene Editing news with our dedicated feed, covering everything from cutting-edge research and clinical trials to policy developments and societal debates, as this transformative technology continues to shape our future.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.